Heal-Or Announces Auspicious Results Of Clinical Trials With Its Leading Product (HO-03-03) For Curing Chronic Wounds

Published: Dec 21, 2006

Heal-Or, (www.healor.com) a biopharmaceutical company focused on the development of therapeutics for wound healing and various skin disorders announces auspicious results of phase I clinical trials with its leading product "HO-03-03" for curing chronic wounds, that are currently conducted in 3 medical centers in Israel. The company has recently begun the regulatory practice necessary for receiving FDA approval to conduct clinical trials in the US.

Back to news